Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
GBA2 encodes a microsomal beta-glucosidase that catalyzes the hydrolysis of bile acid 3-O-glucosides as endogenous compounds. Additionally we are shipping GBA2 Antibodies (25) and many more products for this protein.
Showing 5 out of 5 products:
GBA2 loss of function led to abnormal motor behavior and axonal shortening/branching of motoneurons.
GBA2 is particularly abundant in Purkinje cells (PCs), one of the most affected neuronal populations in NPC (show NPC1 Proteins) disease.
glucosylceramide accumulation in GBA2 knockout-mice alters cytoskeletal dynamics due to a more ordered lipid organization in the plasma membrane. Similar cytoskeletal defects were observed in male germ and Sertoli cells from GBA2 knockout-mice.
the deletion of Gba2 significantly rescues the type 1 Gaucher disease clinical phenotype.
redefine GBA2 activity as the beta-glucosidase that is sensitive to inhibition by N-butyldeoxygalactonojirimycin.
GBA2 is localized at the ER and Golgi, which puts GBA2 in a key position for a lysosome-independent route of glucosylceramide-dependent signaling.
The repression of IL-6 (show IL6 Proteins)/STAT3 (show STAT3 Proteins) signalling pathway seems to be one of the mechanisms for the delay of liver regeneration in GBA2-deficient mice.
GBA1 (show GBA Proteins) and GBA2 activities had characteristic differences between the studied fibroblast, liver and brain samples.
The coiled-coil structure of LIMP-2 is required for its interaction wit (show SCARB2 Proteins)h beta-glucocerebrosidase.
L-type calcium channel blockers have the ex vivo effects of increasing GCase (show GBA Proteins) activity and protein in mouse fibroblasts
GBA2 is a glucosylceramidase (show GBA Proteins) whose loss causes accumulation of glycolipids and an endoplasmic reticulum storage disease
Spastic paraplegia/cerebellar ataxia (show USP14 Proteins) patients have a severe deficit in GBA2 activity, because the GBA2 mutants are intrinsically inactive and/or reduced in amount.
The GBA2 gene shows a low mutation frequency in a general population of complicated hereditary spastic paraparesis
Whole-exome and targeted sequencing have defined the genetic basis of dizziness including new genes causing ataxia (show USP14 Proteins): GBA2, TGM6 (show TGM5 Proteins), ANO10 (show ANO10 Proteins) and SYT14 (show SYT14 Proteins)
We hereby report a novel GBA2 mutation associated with spastic ataxia (show USP14 Proteins) and suggest that GBA2 mutations may be a relatively frequent cause of autosomal recessive cerebellar ataxias.
observations make GBA2 a likely candidate to be involved in Gaucher disease etiology.
This study suggests GBA2 mutations are a cause of recessive spastic ataxia (show USP14 Proteins) and responsible for a form of glucosylceramide storage disease in humans.
GBA2 is down-regulated in melanoma; inducible expression of GBA2 affects endogenous sphingolipid metabolism by promoting glucosylceramide degradation (decrease by 78%) and ceramide generation.
This gene encodes a microsomal beta-glucosidase that catalyzes the hydrolysis of bile acid 3-O-glucosides as endogenous compounds. Studies to determine subcellular localization of this protein in the liver indicated that the enzyme was mainly enriched in the microsomal fraction where it appeared to be confined to the endoplasmic reticulum. This putative transmembrane protein is thought to play a role in carbohydrate transport and metabolism.
bile acid beta-glucosidase
, talin 1
, glucosidase, beta (bile acid) 2
, non-lysosomal glucosylceramidase-like
, beta-glucocerebrosidase 2
, beta-glucosidase 2
, bile acid
, glucosylceramidase 2
, non-lysosomal glucosylceramidase